Nature's Sunshine Shares Fall Premarket After Shanghai Fosun Sells Stake

Dow Jones

06/26

By Colin Kellaher

Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount.

Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84.

Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading.

Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests.

Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility.

The company said it also may buy back up to $15 million worth of the shares Fosun is selling.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

June 26, 2025 07:29 ET (11:29 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2546782734"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2546782734\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2546782734?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-26 19:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2546782734","market":"sg","top_or_hot":-1,"title":"Nature's Sunshine Shares Fall Premarket After Shanghai Fosun Sells Stake","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount. \n</p>\n<p>\n  Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84. \n</p>\n<p>\n  Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading. \n</p>\n<p>\n  Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests. \n</p>\n<p>\n  Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility. \n</p>\n<p>\n  The company said it also may buy back up to $15 million worth of the shares Fosun is selling. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 26, 2025 07:29 ET (11:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nature's Sunshine Shares Fall Premarket After Shanghai Fosun Sells Stake</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNature's Sunshine Shares Fall Premarket After Shanghai Fosun Sells Stake\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-06-26 19:29</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount. \n</p>\n<p>\n  Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84. \n</p>\n<p>\n  Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading. \n</p>\n<p>\n  Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests. \n</p>\n<p>\n  Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility. \n</p>\n<p>\n  The company said it also may buy back up to $15 million worth of the shares Fosun is selling. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 26, 2025 07:29 ET (11:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1230","symbol_name":"工業集團企業","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2546782734","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2546782734","pubTimestamp":1750937340,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount.Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84.Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading.Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests.Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility.The company said it also may buy back up to $15 million worth of the shares Fosun is selling.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600196":"复星医药","BK1230":"工业集团企业","BK1515":"抗疫概念","BK0196":"行业龙头","00656":"复星国际","02196":"复星医药","BK0239":"医药制造","BK0096":"民营医院","BK1543":"农业股票概念","NATR":"天然阳光产品","BK1113":"化肥与农用药剂","BK0183":"MSCI概念","BK4183":"个人用品","BK0188":"融资融券","BK0012":"证金概念","BK0187":"一线龙头","BK0028":"国家队","00509":"世纪阳光(新)","BK1191":"制药","BK1593":"医美概念股","BK0175":"白马股","BK0060":"抗癌"},"translate_title":"上海复星出售股份后，大自然阳光股价盘前下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600196":0.9,"00509":1,"00656":1,"02196":0.9,"NATR":0.9},"content_text":"By Colin Kellaher \n\n\n \n\n\n  Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount. \n\n\n  Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84. \n\n\n  Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading. \n\n\n  Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests. \n\n\n  Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility. \n\n\n  The company said it also may buy back up to $15 million worth of the shares Fosun is selling. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 26, 2025 07:29 ET (11:29 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}